Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04926181
Title Apalutamide Plus Cetrelimab in Patients With Treatment-Emergent Small Cell Neuroendocrine Prostate Cancer
Recruitment Recruiting
Gender male
Phase Phase II
Variant Requirements Yes
Sponsors Rahul Aggarwal
Indications

prostate adenocarcinoma

castration-resistant prostate carcinoma

prostate neuroendocrine neoplasm

Therapies

Apalutamide + Cetrelimab

Age Groups: adult | senior
Covered Countries USA

Additional content available in CKB BOOST